{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:43:35Z","timestamp":1777995815683,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Biomedical Advanced Research and Development Authority (BARDA, HHS)","award":["HHSO100200900106C"],"award-info":[{"award-number":["HHSO100200900106C"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.097","type":"journal-article","created":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T10:01:04Z","timestamp":1446372064000},"page":"6622-6628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Randomized comparison of the safety of Flublok\u00ae versus licensed inactivated influenza vaccine in healthy, medically stable adults \u226550 years of age"],"prefix":"10.1016","volume":"33","author":[{"given":"Ruvim","family":"Izikson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Leffell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Allan","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Patriarca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Dunkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon M.J.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.097_bib0110","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/jama.1985.03350320060017","article-title":"Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during influenza A(H3N2) epidemic","volume":"253","author":"Patriarca","year":"1985","journal-title":"J Amer Med Assn"},{"issue":"Aug (33)","key":"10.1016\/j.vaccine.2015.10.097_bib0115","first-page":"1128","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Centers for Disease Control Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0120","doi-asserted-by":"crossref","first-page":"e92153","DOI":"10.1371\/journal.pone.0092153","article-title":"Low 2012\u201313 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses","volume":"9","author":"Skowronski","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0125","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.jip.2011.05.003","article-title":"A fast track influenza virus vaccine produced in insect cells","volume":"107","author":"Cox","year":"2011","journal-title":"J Invert Pathol"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0130","series-title":"CDC Advisory Committee recommends an influenza vaccine option for persons with egg allergy","author":"Centers for Disease Control and Prevention","year":"2013"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0135","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/infdis\/171.6.1595","article-title":"Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well-tolerated and induce protective immune responses in healthy adults","volume":"171","author":"Powers","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/infdis\/175.2.342","article-title":"Humoral and cellular immune responses following immunization with purified recombinany hemagglutinin from influenza A (H3N2) virus","volume":"175","author":"Powers","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0145","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/infdis\/174.4.838","article-title":"Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults","volume":"174","author":"Lakey","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0150","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/503050","article-title":"Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults","volume":"193","author":"Treanor","year":"2006","journal-title":"J Infect Dis"},{"issue":"29","key":"10.1016\/j.vaccine.2015.10.097_bib0155","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.1016\/j.vaccine.2011.07.128","article-title":"Protective efficacy of a trivalent, insect cell-expressed, recombinant hemagglutinin protein vaccine (FluBlok) against culture confirmed influenza in healthy adults: a randomized, placebo-controlled trial","volume":"13","author":"Treanor","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0160","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.297.14.1577","article-title":"Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial","volume":"297","author":"Treanor","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.vaccine.2009.10.037","article-title":"Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccines (TIVs) among persons \u226565 years old","volume":"28","author":"Keitel","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0170","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.vaccine.2011.01.039","article-title":"Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50\u201364 years of age","volume":"29","author":"Baxter","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0175","series-title":"AFLURIA package insert","author":"bioCSL (CSL Ltd.)","year":"2014"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0180","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/sim.4780091208","article-title":"Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk","volume":"9","author":"Farrington","year":"1990","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1473-3099(14)71087-4","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis","volume":"15","author":"Izurieta","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0190","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of high-dose versus standard-dose influenza vaccine in older adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0195","unstructured":"MedCalc. Version 15.10 - Last modified: October 22, 2015. [Online] \u3008http:\/\/www.medcalc.org\/calc\/relative_risk.php\u3009."},{"key":"10.1016\/j.vaccine.2015.10.097_bib0200","series-title":"Fluzone package insert","author":"Sanofi-Pasteur","year":"2014"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0205","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciu948","article-title":"Egg-free influenza vaccine linked to allergic reaction: reports to the US Vaccine Adverse Event Reporting System","volume":"60","author":"Woo","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.097_bib0210","unstructured":"CDC\/FDA. VAERS. [Online] [Cited: December 11, 2014] \u3008https:\/\/vaers.hhs.gov\/index\u3009."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T04:25:27Z","timestamp":1537244727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":21,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15015534"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.097","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized comparison of the safety of Flublok\u00ae versus licensed inactivated influenza vaccine in healthy, medically stable adults \u226550 years of age","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}